Table 1.

Summary characteristics of CQ-treated patients

	Cases*	Controls †	p-value (two-sided t-test)
Number of Individuals	24	13	-
Mean Age (S.D.) [years]	61.18 (10.45)	49.11 (9.74)	0.0016
Treatment Duration (S.D.) [months]	153.1 (97.77)	121.8 (58.74)	0.2327
Daily dose per body weight (S.D.) [mg/kg]	4.00 (1.26)	3.90 (0.84)	0.7966
Daily dose per ideal weight (S.D.) [mg/kg]	4.90 (1.25)	4.07 (0.31)	0.0078
Fraction of Individuals > 60 years	0.71	0.15	-
Male [%]	0.04	0.23	0.1622

^*Patients treated with CQ and affected with toxic maculopathy.

^†Patients treated with CQ and no signs of toxic maculopathy.